Foundational characteristics of cancer include proliferation, angiogenesis, migration, evasion of apoptosis, and cellular immortality. Find key markers for these cellular processes and antibodies to detect them.
The SUMOplot™ Analysis Program predicts and scores sumoylation sites in your protein. SUMOylation is a post-translational modification involved in various cellular processes, such as nuclear-cytosolic transport, transcriptional regulation, apoptosis, protein stability, response to stress, and progression through the cell cycle.
The Autophagy Receptor Motif Plotter predicts and scores autophagy receptor binding sites in your protein. Identifying proteins connected to this pathway is critical to understanding the role of autophagy in physiological as well as pathological processes such as development, differentiation, neurodegenerative diseases, stress, infection, and cancer.
HTR2C Antibody (Center) Blocking peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
| Primary Accession | P28335 |
|---|---|
| Clone Names | 100430240 |
| Gene ID | 3358 |
|---|---|
| Other Names | 5-hydroxytryptamine receptor 2C, 5-HT-2C, 5-HT2C, 5-HTR2C, 5-hydroxytryptamine receptor 1C, 5-HT-1C, 5-HT1C, Serotonin receptor 2C, HTR2C, HTR1C |
| Target/Specificity | The synthetic peptide sequence used to generate the antibody AP13896c was selected from the Center region of HTR2C. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay. |
| Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
| Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
| Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
| Name | HTR2C (HGNC:5295) |
|---|---|
| Synonyms | HTR1C |
| Function | G-protein coupled receptor for 5-hydroxytryptamine (serotonin). Also functions as a receptor for various drugs and psychoactive substances, including ergot alkaloid derivatives, 1-2,5,- dimethoxy-4-iodophenyl-2-aminopropane (DOI) and lysergic acid diethylamide (LSD). Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors. Beta-arrestin family members inhibit signaling via G proteins and mediate activation of alternative signaling pathways. Signaling activates a phosphatidylinositol-calcium second messenger system that modulates the activity of phosphatidylinositol 3-kinase and down-stream signaling cascades and promotes the release of Ca(2+) ions from intracellular stores. Regulates neuronal activity via the activation of short transient receptor potential calcium channels in the brain, and thereby modulates the activation of pro-opiomelacortin neurons and the release of CRH that then regulates the release of corticosterone. Plays a role in the regulation of appetite and eating behavior, responses to anxiogenic stimuli and stress. Plays a role in insulin sensitivity and glucose homeostasis. |
| Cellular Location | Cell membrane; Multi-pass membrane protein |
| Tissue Location | Detected in brain.. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
Serotonin (5-hydroxytryptamine, 5-HT), a neurotransmitter,elicits a wide array of physiological effects by binding to severalreceptor subtypes, including the 5-HT2 family ofseven-transmembrane-spanning, G-protein-coupled receptors, whichactivate phospholipase C and D signaling pathways. This geneencodes the 2C subtype of serotonin receptor and its mRNA issubject to multiple RNA editing events, where genomically encodedadenosine residues are converted to inosines. RNA editing ispredicted to alter amino acids within the second intracellular loopof the 5-HT2C receptor and generate receptor isoforms that differin their ability to interact with G proteins and the activation ofphospholipase C and D signaling cascades, thus modulatingserotonergic neurotransmission in the central nervous system.Studies in humans have reported abnormalities in patterns of 5-HT2Cediting in depressed suicide victims.
References
Gregoor, J.G., et al. Psychiatr. Genet. 20(6):311-316(2010)Bailey, S.D., et al. Diabetes Care 33(10):2250-2253(2010)Kiezebrink, K., et al. World J. Biol. Psychiatry 11(6):824-833(2010)Risselada, A.J., et al. Pharmacogenomics J. (2010) In press :McGrew, L., et al. Mol. Pharmacol. 65(1):252-256(2004)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.
Ordering Information
Other Products
Shipping Information
